XML 15 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Earnings (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Net Sales $ 2,017.6 $ 1,972.4
Cost of products sold, excluding intangible asset amortization 575.8 512.9
Intangible asset amortization 150.8 152.0
Research and development 95.7 91.1
Selling, general and administrative 785.1 758.2
Acquisition, quality remediation and other (Note 4) 105.2 110.1
Operating expenses 1,712.6 1,624.3
Operating Profit 305.0 348.1
Other expense, net (3.6) (0.5)
Interest income 0.9 0.5
Interest expense (78.9) (82.9)
Earnings before income taxes 223.4 265.2
Provision (benefit) for income taxes 47.2 (34.1)
Net Earnings 176.2 299.3
Less: Net earnings (loss) attributable to noncontrolling interest 1.5 (0.1)
Net Earnings of Zimmer Biomet Holdings, Inc. $ 174.7 $ 299.4
Earnings Per Common Share    
Basic $ 0.86 $ 1.49
Diluted $ 0.85 $ 1.47
Weighted Average Common Shares Outstanding    
Basic 203.0 201.1
Diluted 204.6 203.1
Cash Dividends Declared Per Common Share $ 0.24 $ 0.24